These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
303 related items for PubMed ID: 16902598
1. Montelukast prevents the decrease of interleukin-10 and inhibits NF-kappaB activation in inflammatory airway of asthmatic guinea pigs. Wu Y, Zhou C, Tao J, Li S. Can J Physiol Pharmacol; 2006 May; 84(5):531-7. PubMed ID: 16902598 [Abstract] [Full Text] [Related]
2. The effect of treatment with montelukast on levels of serum interleukin-10, eosinophil cationic protein, blood eosinophil counts, and clinical parameters in children with asthma. Yüksel B, Aydemir C, Ustündag G, Eldeş N, Kutsal E, Can M, Demirtaş S, Tomaç N. Turk J Pediatr; 2009 May; 51(5):460-5. PubMed ID: 20112601 [Abstract] [Full Text] [Related]
3. Effect of montelukast on nuclear factor kappaB activation and proinflammatory molecules. Maeba S, Ichiyama T, Ueno Y, Makata H, Matsubara T, Furukawa S. Ann Allergy Asthma Immunol; 2005 Jun; 94(6):670-4. PubMed ID: 15984600 [Abstract] [Full Text] [Related]
4. Effects of a cysteinyl leukotriene dual 1/2 receptor antagonist on antigen-induced airway hypersensitivity and airway inflammation in a guinea pig asthma model. Muraki M, Imbe S, Santo H, Sato R, Sano H, Iwanaga T, Tohda Y. Int Arch Allergy Immunol; 2011 Jun; 155 Suppl 1():90-5. PubMed ID: 21646802 [Abstract] [Full Text] [Related]
6. Montelukast and bronchial inflammation in asthma: a randomised, double-blind placebo-controlled trial. Ramsay CF, Sullivan P, Gizycki M, Wang D, Swern AS, Barnes NC, Reiss TF, Jeffery PK. Respir Med; 2009 Jul; 103(7):995-1003. PubMed ID: 19249198 [Abstract] [Full Text] [Related]
7. Administration of antisense phosphorothioate oligonucleotide to the p65 subunit of NF-kappaB inhibits established asthmatic reaction in mice. Choi IW, Kim DK, Ko HM, Lee HK. Int Immunopharmacol; 2004 Dec 20; 4(14):1817-28. PubMed ID: 15531297 [Abstract] [Full Text] [Related]
8. Effects of (±)-praeruptorin A on airway inflammation, airway hyperresponsiveness and NF-κB signaling pathway in a mouse model of allergic airway disease. Xiong Y, Wang J, Wu F, Li J, Zhou L, Kong L. Eur J Pharmacol; 2012 May 15; 683(1-3):316-24. PubMed ID: 22449378 [Abstract] [Full Text] [Related]
9. Antagonistic effects of nobiletin, a polymethoxyflavonoid, on eosinophilic airway inflammation of asthmatic rats and relevant mechanisms. Wu YQ, Zhou CH, Tao J, Li SN. Life Sci; 2006 May 01; 78(23):2689-96. PubMed ID: 16337971 [Abstract] [Full Text] [Related]
10. [Effects of montelukast on apoptosis and Fas mRNA expression of eosinophils in airway of asthmatic guinea pigs]. Wu YQ, Zhou CH, Zhang HQ. Yao Xue Xue Bao; 2004 Oct 01; 39(10):769-73. PubMed ID: 15700813 [Abstract] [Full Text] [Related]
11. Anti-inflammatory mechanism of simvastatin in mouse allergic asthma model. Kim DY, Ryu SY, Lim JE, Lee YS, Ro JY. Eur J Pharmacol; 2007 Feb 14; 557(1):76-86. PubMed ID: 17169357 [Abstract] [Full Text] [Related]
12. Inhaled montelukast inhibits cysteinyl-leukotriene-induced bronchoconstriction in ovalbumin-sensitized guinea-pigs: the potential as a new asthma medication. Muraki M, Imbe S, Sato R, Ikeda Y, Yamagata S, Iwanaga T, Tohda Y. Int Immunopharmacol; 2009 Oct 14; 9(11):1337-41. PubMed ID: 19706339 [Abstract] [Full Text] [Related]
13. Comparison study between the mechanisms of allergic asthma amelioration by a cysteinyl-leukotriene type 1 receptor antagonist montelukast and methylprednisolone. Murai A, Abe M, Hayashi Y, Sakata N, Katsuragi T, Tanaka K. J Pharmacol Exp Ther; 2005 Feb 14; 312(2):432-40. PubMed ID: 15470084 [Abstract] [Full Text] [Related]
14. Effects of glucocorticoid and cysteinyl leukotriene 1 receptor antagonist on CD(34+) hematopoietic cells in bone marrow of asthmatic mice. Mao H, Yin KS, Wang ZL, Li FY, Zhang XL, Liu CT, Lei S. Chin Med J (Engl); 2004 Apr 14; 117(4):592-7. PubMed ID: 15109455 [Abstract] [Full Text] [Related]
15. [The effects of anti-inflammatory and anti-asthmatic agents on CD34+ hematopoietic cells in bone marrow of asthmatic mice]. Mao H, Wang ZL, Liu CT, Yin KS, Yu YH, Deng YL. Zhonghua Jie He He Hu Xi Za Zhi; 2004 Apr 14; 27(4):229-33. PubMed ID: 15144611 [Abstract] [Full Text] [Related]
16. Therapeutic potential of anti-IL-1β IgY in guinea pigs with allergic asthma induced by ovalbumin. Wei-xu H, Qin X, Zhu W, Yuan-yi C, Li-feng Z, Zhi-yong L, Dan H, Xiao-mu W, Guo-zhu H. Mol Immunol; 2014 Mar 14; 58(1):139-49. PubMed ID: 24355520 [Abstract] [Full Text] [Related]
17. Montelukast inhibits tumour necrosis factor-alpha-mediated interleukin-8 expression through inhibition of nuclear factor-kappaB p65-associated histone acetyltransferase activity. Tahan F, Jazrawi E, Moodley T, Rovati GE, Adcock IM. Clin Exp Allergy; 2008 May 14; 38(5):805-11. PubMed ID: 18325031 [Abstract] [Full Text] [Related]
18. Suppression of ovalbumin-induced Th2-driven airway inflammation by β-sitosterol in a guinea pig model of asthma. Mahajan SG, Mehta AA. Eur J Pharmacol; 2011 Jan 10; 650(1):458-64. PubMed ID: 20946894 [Abstract] [Full Text] [Related]
19. [An experimental study on the regulation of the expression of Th2 cytokines by nuclear factor-kappaB and protein kinase C in asthma]. Xiong W, Xu Y, Zhang Z. Zhonghua Jie He He Hu Xi Za Zhi; 2001 Jun 10; 24(6):355-9. PubMed ID: 11802989 [Abstract] [Full Text] [Related]
20. Narirutin inhibits airway inflammation in an allergic mouse model. Funaguchi N, Ohno Y, La BL, Asai T, Yuhgetsu H, Sawada M, Takemura G, Minatoguchi S, Fujiwara T, Fujiwara H. Clin Exp Pharmacol Physiol; 2007 Aug 10; 34(8):766-70. PubMed ID: 17600554 [Abstract] [Full Text] [Related] Page: [Next] [New Search]